L’évolution de la pandémie dans cinq pays de la péninsule indochinoise : Cambodge, Laos, Myanmar, Thaïlande et Viêt Nam. Sur la plateforme de Open Development Mekong.
Étiqueté : Thaïlande
La situation épidémique dans des pays en Asie du Sud-Est continue de s’aggraver avec le nombre de nouveaux cas en augmentation continuelle chaque jour.
Private hospitals and drugmakers in Thailand are seeking approval from the government to import several COVID-19 vaccines independently to meet demand from wealthy Thais and companies that want to receive their choice of shots as quickly as possible.
Under the government’s vaccination program that kicked off March 1, only two vaccines, made by China’s Sinovac and the U.K.’s AstraZeneca, will be distributed through public hospital networks free of charge. Private businesses now want to offer fast-track inoculations for those who are willing to pay.
Following the production of its second domestically developed COVID-19 vaccine, Thailand is all set to commence its human trials from as early as April this year.
The vaccine which was developed by Chulalongkorn University showed promising results in prior trials with mice and monkeys. The University’s Centre of Excellence in Vaccine Research and Development is utilizing new mRNA technology and its clinical testing on transgenic mice showed that the vaccine was able to prevent clinical symptoms and viremia after two shots. The university is looking to enroll 72 participants in the first phase of the human trials and subsequently increase the number to 300-600 participants in the second phase. The university has also begun research on a second-generation vaccine that will help grant additional protection to its citizens against the UK and South African variants of the COVID-19 virus.
Thailand will start vaccinating priority groups including health workers against COVID-19 by the end of this week, its prime minister said on Tuesday, a day ahead of the arrival of the country’s first coronavirus vaccines.
[Thaïlande] Coronavirus disease 2019 (COVID-19) WHO Thailand Situation Report – 22 February 2021 [EN/TH]
On 22nd February, 89 new cases of laboratory-confirmed COVID-19 were announced by the Ministry of Public Health of Thailand bringing the total number of cases to date to 25,504. No new deaths were reported today.
• Of the cases reported in Thailand to date, 95.5% (24,361) have recovered, 0.3% (83) have died, and 4.2% (1,060) are receiving treatment or are in isolation (736 are in conventional hospitals and 324 in field hospitals).
A second wave of Covid-19 infections in Thailand is taking a serious toll on migrant workers from Myanmar, as they face not only health risks and economic losses, but also discrimination from their hosts.
[Asie] Coronavirus: China’s Sinovac shots readied for mass roll-out in Indonesia, Philippines and Thailand
– Indonesian President Joko Widodo will be the first to get the jab when inoculations begin on January 13
– The Philippines and Thailand are also expected to receive millions of doses in coming months
Le Laos a temporairement interdit les importations de produits aquatiques en provenance de Thaïlande, après une nouvelle vague de l’épidémie de COVID-19 qui se déclare dans ce pays.
[Thaïlande] AstraZeneca to manufacture 200 mln anti-COVID vaccine doses in Thailand, says virologist
AstraZeneca, a British-Swedish pharmaceutical company, will produce 200 million doses of its anti-coronavirus vaccine in Thailand next year with the help of Siam Bioscience, director of Thailand’s National Vaccine Institute Dr. Nakorn Premsri, said in an interview with TASS.
“AstraZeneca is hiring the Thai company Siam Bioscience to produce the vaccine,” he explained. “The capacity will be 200 million doses of the vaccine per year. The Thai government has reserved 26 million doses for itself. This is the first batch of the vaccine to be available in May or June 2021.”
According to Dr. Premsri, from 5 million to 10 million people can be vaccinated in Thailand per month.
The Thai authorities are only looking at possible use of the Russian Sputnik V anti-coronavirus as they want to know long-term results of its use, director of Thailand’s National Vaccine Institute Dr. Nakorn Premsri said in an interview with TASS.
La Thaïlande déclare pouvoir échapper à une deuxième vague d’infections de COVID-19, tandis que les Philippines et l’Indonésie continuent d’enregistrer de nouveaux cas de contamination.
Thailand has been internationally praised for avoiding a COVID-19 disaster. Despite recording the first case of the virus outside of China on 13 January 2020, Thailand managed to avoid its first death until almost seven weeks later. Its peak of new daily COVID-19 cases was 188 in late March — a low figure compared to many Western countries.